The past decade has revealed much about the complexity of the local inflammatory response after spinal cord injury (SCI). A major challenge is to distinguish between microglia and monocyte-derived macrophages (MDMs) to determine their phenotype and function. Transcriptome studies have revealed microglia-selective genes but are still limited in scope because many markers are downregulated after injury. Additionally, new genetic reporter mice are available to study microglia and MDMs. There is more evidence now for the plasticity and heterogeneity of microglia and MDMs. We also discuss the role of neutrophils that are the first peripheral cells to enter the injured CNS.
Introduction
Spinal cord injury (SCI) results in loss of motor, sensory and autonomic function below the level of lesion. This is due in large part to the inability of damaged axons to regenerate in the CNS environment and to the limited ability of the CNS to replace lost neurons. There are currently no effective treatments to improve neurological outcome after SCI in humans. As would be expected, much of the research effort has been devoted to studies to promote axon regeneration and re-establishment of damaged circuitry (Borton et al., 2014; Filli and Schwab, 2015; Kadoya et al., 2016; Lu et al., 2017) . In addition, attention has also focused on reducing secondary tissue damage that occurs in the days, weeks and months following injury (David et al., 2012) . Preventing secondary damage has been shown to improve histological and functional outcome in experimental animal models of SCI (Gris et al., 2004; Ghasemlou et al., 2010a; Ghasemlou et al., 2010b; Lopez-Vales et al., 2010; Lopez-Vales et al., 2011) . Although several factors, including hemorrhage and ischemia (Tator and Koyanagi, 1997; Rathore et al., 2008; Kroner et al., 2014) contribute to such damage, the inflammatory response is generally thought to contribute importantly to secondary damage after spinal cord trauma. Evidence that the inflammatory response is detrimental after SCI comes from experiments in which anti-inflammatory treatments show improvement (Mabon et al., 2000; Wells et al., 2003; Gris et al., 2004; Stirling et al., 2004; Fleming et al., 2008; Kerr et al., 2008; Lopez-Vales et al., 2011) . These detrimental effects are thought to be mediated in part by macrophages/ microglia (Gris et al., 2004; Kigerl et al., 2009; Kroner et al., 2014) . However, macrophage/microglia are also known to have beneficial and pro-repair effects (Shechter et al., 2009) . Factors that influence the nature of these cells are now beginning to be understood. These include both extrinsic factors in the tissue environment (cytokines, growth factors, and others) and intrinsic factors triggered by what these cells phagocytose that influence the activation or polarization state of these cells (David and Kroner, 2011; David et al., 2015) . However, the control of the plasticity of these cells is not yet fully understood. A better understanding of the factors that control the dual nature of these cells will help in the development of therapeutic strategies to reduce damage after spinal cord trauma.
Microglia and peripheral macrophages infiltrating into the CNS from the circulation arise from different myeloid origins. Microglia are the resident tissue macrophages of the CNS, which differ from macrophages that infiltrate into the CNS after injury or disease, and also from macrophages present in the normal CNS in border regions such as the meninges, perivascular spaces and choroid plexus (David and Kroner, 2011; Goldmann et al., 2016; Korin et al., 2017) . In the subsequent section, we will discuss further the origins of the cells. Several recent studies have shown that these cell types have distinctly different gene expression signatures. These studies have led to the identification of
